Back
Xenon Pharmaceuticals Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
38
XENE
Xenon Pharmaceuticals
Last Price:
$38.64
Seasonality Move:
18.17%
Buy
56
AUPH
Aurinia Pharmaceuticals
Last Price:
$9.04
Seasonality Move:
22.59%
Sell
38
Xenon Pharmaceuticals (XENE)
is a Sell
Is Xenon Pharmaceuticals a Buy, Sell or Hold?
-
The current Xenon Pharmaceuticals [XENE] share price is $38.69. The Score for XENE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
XENE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
-
The current Aurinia Pharmaceuticals [AUPH] share price is $9.03. The Score for AUPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
AUPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XENE Stock Price Chart
What is Xenon Pharmaceuticals's stock price today?
-
The Xenon Pharmaceuticals share price today is $38.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XENE is experiencing slight selling pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $9.03The current trend is moderately bearish and AUPH is experiencing slight selling pressure.
XENE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 39.43 | Sell |
Chaikin Money Flow: | -46586 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.46 - 42.44) | Sell |
Bollinger Bands (100): | (39.14 - 42.6) | Sell |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 51.75 | Buy |
Chaikin Money Flow: | -459691 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.42 - 9.56) | Buy |
Bollinger Bands (100): | (6.26 - 8.56) | Buy |
XENE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.27 | Sell |
20-day SMA: | 41.39 | Sell |
50-day SMA: | 41.81 | Sell |
200-day SMA: | 40.85 | Sell |
8-day EMA: | 40.05 | Sell |
20-day EMA: | 40.88 | Sell |
50-day EMA: | 41.22 | Sell |
200-day EMA: | 40.85 | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.44 | Sell |
20-day SMA: | 9.18 | Sell |
50-day SMA: | 8.24 | Buy |
200-day SMA: | 6.37 | Buy |
8-day EMA: | 9.27 | Sell |
20-day EMA: | 9.09 | Sell |
50-day EMA: | 8.42 | Buy |
200-day EMA: | 7.26 | Buy |
Xenon Pharmaceuticals Earnings Growth & XENE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.43 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Xenon Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |